Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1350 of 1467 entries
View as:

VIsceral Fat Reduction Assessed by CT-scan On RImonabAnt

Phase: N/A Priority: Normal
NCT ID: NCT00299325 Org: User:
Start: 02/28/06 End: 07/31/08 Due: 07/31/09

Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion

Phase: N/A Priority: Normal
NCT ID: NCT00032734 Org: User:
Start: 06/30/01 End: 07/31/03 Due: 07/31/04

Dose-Exposure-Response in Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00368394 Org: User:
Start: 01/31/04 End: - Due: -

Glimepiride vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00353691 Org: User:
Start: 10/31/02 End: 11/30/04 Due: 11/30/05

A Food Effect and Relative Bioavailability Study of Rilzabrutinib in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06342700 Org: User:
Start: 03/25/24 End: 04/23/24 Due: 04/23/25

A Study of an Existing Database to Assess the Treatment Persistence to Basal Insulin in Type 2 Diabetes Mellitus Patients in a Structured Patient Education Program in India

Phase: N/A Priority: Normal
NCT ID: NCT05628090 Org: User:
Start: 11/30/22 End: 12/29/23 Due: 12/29/24

The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing

Phase: N/A Priority: Normal
NCT ID: NCT00609895 Org: User:
Start: 01/31/04 End: 08/31/04 Due: 08/31/05

Larotaxel + Cisplatin Versus Gemcitabine + Cisplatin in First Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00625664 Org: User:
Start: 02/29/08 End: 02/28/11 Due: 02/28/12

Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze

Phase: N/A Priority: Normal
NCT ID: NCT00668577 Org: User:
Start: 12/31/07 End: - Due: -

PH Metry Study to Compare the Antacid Activity of Z0063 Versus Gaviscon Double Action Tablets, in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03069963 Org: User:
Start: 02/24/17 End: 04/23/17 Due: 04/23/18

Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant

Phase: N/A Priority: Normal
NCT ID: NCT00228176 Org: User:
Start: 08/31/05 End: 04/30/09 Due: 04/30/10

Efficacy and Safety of Efpeglenatide Versus Dulaglutide in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin

Phase: N/A Priority: Normal
NCT ID: NCT03684642 Org: User:
Start: 09/26/18 End: 11/17/20 Due: 11/17/21

Observational Study of Canadian Patients (6 Years or Older) Receiving Dupixent® for Moderate to Severe Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT06099704 Org: User:
Start: 10/10/23 End: 04/10/26 Due: 04/10/27

A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT01439919 Org: User:
Start: 01/31/12 End: 02/29/12 Due: 02/28/13

Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00285077 Org: User:
Start: 03/31/04 End: 11/30/06 Due: 11/30/07

A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

Phase: N/A Priority: Normal
NCT ID: NCT05797753 Org: User:
Start: 02/18/22 End: 07/01/22 Due: 07/01/23

TOFO Insulin Combination Trial

Phase: N/A Priority: Normal
NCT ID: NCT02201004 Org: User:
Start: 06/30/14 End: 10/31/16 Due: 10/31/17

Study to Evaluate DNL747 in Subjects With Amyotrophic Lateral Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT03757351 Org: User:
Start: 12/14/18 End: 06/18/20 Due: 06/18/21

Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Tusamitamab Ravtansine (SAR408701) in Combination With Pembrolizumab and Platinum-based Chemotherapy With or Without Pemetrexed in Patients With NSQ NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT04524689 Org: User:
Start: 10/26/20 End: 12/24/24 Due: 12/24/25

Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)

Phase: N/A Priority: Normal
NCT ID: NCT00917748 Org: User:
Start: 06/30/09 End: 03/31/11 Due: 03/31/12

Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure

Phase: N/A Priority: Normal
NCT ID: NCT01117350 Org: User:
Start: 07/31/10 End: 03/31/13 Due: 03/31/14

A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany

Phase: N/A Priority: Normal
NCT ID: NCT06695897 Org: User:
Start: 12/02/24 End: 05/29/29 Due: 05/29/30

Study of Two Investigational Pneumococcal Vaccines in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT01444339 Org: User:
Start: 02/28/10 End: 09/30/10 Due: 09/30/11

Study of the Safety and Pharmacokinetics of XL765 (SAR245409) in Adults With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00485719 Org: User:
Start: 06/30/07 End: 09/30/12 Due: 09/30/13

STILDEP: Zolpidem in Depressive and Dysthimic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00292734 Org: User:
Start: 01/31/05 End: 06/30/06 Due: 06/30/07